{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T04:40:26Z","timestamp":1721450426751},"reference-count":29,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2024]]},"DOI":"10.5797\/jnet.cr.2024-0023","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:12:13Z","timestamp":1715983933000},"page":"197-202","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome"],"prefix":"10.5797","volume":"18","author":[{"given":"Ryutaro","family":"Makino","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"},{"name":"Department of Neurosurgery, Imamura General Hospital, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Machida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"},{"name":"Department of Neurosurgery, Imamura General Hospital, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"},{"name":"Department of Neurosurgery, Imamura General Hospital, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"},{"name":"Department of Neurosurgery, Imamura General Hospital, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hanaya","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) G\u00f3mez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. <i>J Autoimmun<\/i> 2014; 48\u201349: 20\u201325.","DOI":"10.1016\/j.jaut.2014.01.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Schreiber K, Sciascia S, de Groot PG, et al. Antiphospholipid syndrome. <i>Nat Rev Dis Primers<\/i> 2018; 4: 17103.","DOI":"10.1038\/nrdp.2017.103"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cervera R, Boffa MC, Khamashta MA, et al. The Euro-phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. <i>Lupus<\/i> 2009; 18: 889\u2013893.","DOI":"10.1177\/0961203309106832"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Andreoli L, Chighizola CB, Banzato A, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. <i>Arthritis Care Res (Hoboken)<\/i> 2013; 65: 1869\u20131873.","DOI":"10.1002\/acr.22066"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sciascia S, Sanna G, Khamashta MA, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. <i>Ann Rheum Dis<\/i> 2015; 74: 2028\u20132033.","DOI":"10.1136\/annrheumdis-2014-205663"},{"key":"6","unstructured":"6) Asherson RA. The catastrophic antiphospholipid syndrome. <i>J Rheumatol<\/i> 1992; 19: 508\u2013512."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nojima J, Kuratsune H, Suehisa E, et al. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. <i>Clin Chem<\/i> 2001; 47: 1008\u20131015.","DOI":"10.1093\/clinchem\/47.6.1008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fujieda Y, Atsumi T, Amengual O, et al. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome. <i>Lupus<\/i> 2012; 21: 1506\u20131514.","DOI":"10.1177\/0961203312458469"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Provenzale JM, Barboriak DP, Allen NB, et al. Patients with antiphospholipid antibodies: CT and MR findings of the brain. <i>AJR Am J Roentgenol<\/i> 1996; 167: 1573\u20131578.","DOI":"10.2214\/ajr.167.6.8956600"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miesbach W, Gilzinger A, G\u00f6kpinar B, et al. Prevalence of antiphospholipid antibodies in patients with neurological symptoms. <i>Clin Neurol Neurosurg<\/i> 2006; 108: 135\u2013142.","DOI":"10.1016\/j.clineuro.2005.03.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yang W, Kang DW, Kim JM, et al. Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke. <i>Sci Rep<\/i> 2022; 12: 11686.","DOI":"10.1038\/s41598-022-16019-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. <i>Autoimmun Rev<\/i> 2016; 15: 1120\u20131124.","DOI":"10.1016\/j.autrev.2016.09.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. <i>Arthritis Rheum<\/i> 2006; 54: 2568\u20132576.","DOI":"10.1002\/art.22018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cervera R, Rodr\u00edguez-Pint\u00f3 I, Colafrancesco S, et al. 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. <i>Autoimmun Rev<\/i> 2014; 13: 699\u2013707.","DOI":"10.1016\/j.autrev.2014.03.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. <i>Curr Rheumatol Rep<\/i> 2003; 5: 395\u2013400.","DOI":"10.1007\/s11926-003-0031-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. <i>Autoimmun Rev<\/i> 2010; 10: 74\u201379.","DOI":"10.1016\/j.autrev.2010.08.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cervera R, Font J, G\u00f3mez-Puerta JA, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. <i>Ann Rheum Dis<\/i> 2005; 64: 1205\u20131209.","DOI":"10.1136\/ard.2004.025759"},{"key":"18","unstructured":"18) Conti F, Priori R, Alessandri C, et al. Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests. <i>Clin Exp Rheumatol<\/i> 2017; 35: 678\u2013680."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pignatelli P, Ettorre E, Menichelli D, et al. Seronegative antiphospholipid syndrome: refining the value of \u201cnon-criteria\u201d antibodies for diagnosis and clinical management. <i>Haematologica<\/i> 2020; 105: 562\u2013572.","DOI":"10.3324\/haematol.2019.221945"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Enescu CD, Basida B, Zalavadiya N, et al. A diagnostic dilemma: catastrophic or seronegative antiphospholipid syndrome. <i>Cureus<\/i> 2021; 13: e18745.","DOI":"10.7759\/cureus.18745"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Aguiar CL, Erkan D. Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. <i>Ther Adv Musculoskelet Dis<\/i> 2013; 5: 305\u2013314.","DOI":"10.1177\/1759720X13502919"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sammaritano LR. Antiphospholipid syndrome. <i>Best Pract Res Clin Rheumatol<\/i> 2020; 34: 101463.","DOI":"10.1016\/j.berh.2019.101463"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) L\u00f3pez-Benjume B, Rodr\u00edguez-Pint\u00f3 I, Amigo MC, et al. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): descriptive analysis from the \u201cCAPS Registry.\u201d. <i>Autoimmun Rev<\/i> 2022; 21: 103055.","DOI":"10.1016\/j.autrev.2022.103055"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Coster S, van Dijk LC, Treurniet FE, et al. Successful intra-arterial thrombolysis beyond the accepted 6-hour time window in two young patients. <i>J Neurol Sci<\/i> 2010; 288: 182\u2013185.","DOI":"10.1016\/j.jns.2009.10.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Stadler K, Mutzenbach JS, Kalss G, et al. Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: a case report. <i>Interv Neuroradiol<\/i> 2015; 21: 598\u2013602.","DOI":"10.1177\/1591019915590371"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large ischemic region. <i>N Engl J Med<\/i> 2022; 386: 1303\u20131313.","DOI":"10.1056\/NEJMoa2118191"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Senken B, Whitehead A. Catastrophic antiphospholipid syndrome presenting as a stroke in an 11-year-old with lupus. <i>Case Rep Pediatr<\/i> 2022; 2022: 7890566.","DOI":"10.1155\/2022\/7890566"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tanaka A, Mima Y, Abe Y, et al. A case of catastrophic antiphospholipid syndrome with cerebral venous thrombosis. <i>Jpn J Stroke<\/i> 2020; 42: 429\u2013434. (in Japanese)","DOI":"10.3995\/jstroke.10729"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Abu-Abaa M, Al-Qaysi G, Chadalawada S, et al. A probable catastrophic antiphospholipid antibody syndrome\/thrombotic storm presenting as rapidly evolving multifocal ischemic and hemorrhagic strokes: a case report. <i>Cureus<\/i> 2023; 15: e35584.","DOI":"10.7759\/cureus.35584"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/18\/7\/18_cr.2024-0023\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T04:10:18Z","timestamp":1721448618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/18\/7\/18_cr.2024-0023\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.cr.2024-0023","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"cr.2024-0023"}}